STATKING Consulting, Inc., a provider of data related services for clinical trials, is announcing the hiring of Hussein Al-Khalidi as Director of Biostatistics effective January 5, 2009.
Dr. Al-Khalidi brings a wealth of knowledge and experience to his new role at STATKING Consulting, Inc. Dr. Al-Khalidi has over 15 years of statistical experience in Phase I, II and III clinical trials and pre-clinical development and has extensive experience in designing, sizing and analyzing clinical trials for new drug development with an emphasis on cardiovascular trials.
Prior to joining STATKING Consulting, Inc., Dr. Al-Khalidi was a statistician at Proctor and Gamble Pharmaceuticals (P&GP) and an Adjunct Associate Professor at the University of Cincinnati for the past 15 years. At P&GP, Dr. Al-Khalidi was fully responsible and accountable for statistical leadership in the development and execution of strategies and plans for securing regulatory approval of a new cardiovascular drug as well as a pediatric indication on a marketed osteoporosis drug for children. Dr. Al-Khalidi was also responsible for the statistical leadership of the largest primary percutaneous coronary intervention trial in the United States.
Dr. Al-Khalidi has been the lead statistician for several NDA submissions. He has written statistical analysis plans, interim analysis plans, stand alone statistics reports, the statistical sections of clinical study reports and integrated summaries of efficacy and safety. He has interacted with FDA statisticians and medical personnel both as a representative of his company and also in an advisory capacity. He has particular statistical expertise in the areas of recurrent events analysis, adaptive designs, dose ranging, QT prolongation studies and randomization methods.
Dr. Al-Khalidi earned his PhD in Statistics from Texas A&M University. He has published over 40 articles in a variety of technical and scientific journals. He is the Associate Editor for the Journal of Biopharmaceutical Statistics.
About STATKING Consulting, Inc.
Since 1989, STATKING Consulting, Inc. has provided data related services (biostatistics, clinical data management, clinical study monitoring, medical writing, project management and clinical trial management) for clinical trials for the regulatory approval of novel drug and medical device products. The company is headquartered in Fairfield, OH. The company has provided support on over 250 clinical trials in a variety of drug and medical therapeutic areas. For more information, visit www.statkingconsulting.com.
Contacts:
STATKING Consulting, Inc.
Jeff Osterhaus, Senior Contracts Manager,
513-858-2989 x329
jeff@statkingconsulting.com
